JP4629675B2 - オペレーター不要のプログラム可能な試料調製および分析システム - Google Patents
オペレーター不要のプログラム可能な試料調製および分析システム Download PDFInfo
- Publication number
- JP4629675B2 JP4629675B2 JP2006527036A JP2006527036A JP4629675B2 JP 4629675 B2 JP4629675 B2 JP 4629675B2 JP 2006527036 A JP2006527036 A JP 2006527036A JP 2006527036 A JP2006527036 A JP 2006527036A JP 4629675 B2 JP4629675 B2 JP 4629675B2
- Authority
- JP
- Japan
- Prior art keywords
- sample
- reagent
- tube
- cells
- magnetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000004458 analytical method Methods 0.000 title claims description 22
- 238000002360 preparation method Methods 0.000 title claims description 22
- 239000000523 sample Substances 0.000 claims description 293
- 239000003153 chemical reaction reagent Substances 0.000 claims description 159
- 210000004027 cell Anatomy 0.000 claims description 124
- 238000000034 method Methods 0.000 claims description 102
- 239000012530 fluid Substances 0.000 claims description 98
- 230000005291 magnetic effect Effects 0.000 claims description 77
- 230000008569 process Effects 0.000 claims description 59
- 238000012545 processing Methods 0.000 claims description 36
- 238000004140 cleaning Methods 0.000 claims description 30
- 239000012472 biological sample Substances 0.000 claims description 19
- 239000006249 magnetic particle Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000002699 waste material Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 239000012128 staining reagent Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000010191 image analysis Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims description 3
- 230000001413 cellular effect Effects 0.000 claims description 3
- 210000002889 endothelial cell Anatomy 0.000 claims description 3
- 210000002919 epithelial cell Anatomy 0.000 claims description 3
- 230000002538 fungal effect Effects 0.000 claims description 3
- 238000002372 labelling Methods 0.000 claims description 3
- 210000004881 tumor cell Anatomy 0.000 claims description 3
- 230000005389 magnetism Effects 0.000 claims description 2
- 230000014759 maintenance of location Effects 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 230000003993 interaction Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 239000011554 ferrofluid Substances 0.000 description 32
- 238000000926 separation method Methods 0.000 description 32
- 238000013461 design Methods 0.000 description 23
- 210000003743 erythrocyte Anatomy 0.000 description 23
- 238000011534 incubation Methods 0.000 description 19
- 239000000872 buffer Substances 0.000 description 17
- 238000012546 transfer Methods 0.000 description 17
- 238000007792 addition Methods 0.000 description 16
- 230000033001 locomotion Effects 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 238000007885 magnetic separation Methods 0.000 description 13
- 238000001514 detection method Methods 0.000 description 12
- 210000001938 protoplast Anatomy 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 230000006872 improvement Effects 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 230000002572 peristaltic effect Effects 0.000 description 8
- 210000000805 cytoplasm Anatomy 0.000 description 7
- 239000010808 liquid waste Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 230000037452 priming Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 238000005534 hematocrit Methods 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 206010027476 Metastases Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000013024 dilution buffer Substances 0.000 description 4
- 229910001026 inconel Inorganic materials 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 230000006727 cell loss Effects 0.000 description 3
- 210000003040 circulating cell Anatomy 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000013500 data storage Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000005499 meniscus Effects 0.000 description 3
- 208000037819 metastatic cancer Diseases 0.000 description 3
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000012864 cross contamination Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000007781 pre-processing Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004164 analytical calibration Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002844 continuous effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 239000011553 magnetic fluid Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/0098—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/70—Determining position or orientation of objects or cameras
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Theoretical Computer Science (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50375403P | 2003-09-18 | 2003-09-18 | |
PCT/US2004/030429 WO2005028663A2 (en) | 2003-09-18 | 2004-09-17 | Operator independent programmable sample preparation and analysis system |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010234618A Division JP5215368B2 (ja) | 2003-09-18 | 2010-10-19 | オペレーター不要のプログラム可能な試料調製および分析システム |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007505626A JP2007505626A (ja) | 2007-03-15 |
JP4629675B2 true JP4629675B2 (ja) | 2011-02-09 |
Family
ID=34375391
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006527036A Expired - Lifetime JP4629675B2 (ja) | 2003-09-18 | 2004-09-17 | オペレーター不要のプログラム可能な試料調製および分析システム |
JP2010234618A Expired - Lifetime JP5215368B2 (ja) | 2003-09-18 | 2010-10-19 | オペレーター不要のプログラム可能な試料調製および分析システム |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010234618A Expired - Lifetime JP5215368B2 (ja) | 2003-09-18 | 2010-10-19 | オペレーター不要のプログラム可能な試料調製および分析システム |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1673611A4 (de) |
JP (2) | JP4629675B2 (de) |
CA (1) | CA2539108A1 (de) |
WO (1) | WO2005028663A2 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8986944B2 (en) | 2001-10-11 | 2015-03-24 | Aviva Biosciences Corporation | Methods and compositions for separating rare cells from fluid samples |
US8980568B2 (en) | 2001-10-11 | 2015-03-17 | Aviva Biosciences Corporation | Methods and compositions for detecting non-hematopoietic cells from a blood sample |
JP2006501449A (ja) | 2002-09-27 | 2006-01-12 | ザ ジェネラル ホスピタル コーポレーション | 細胞分離のためのマイクロ流体デバイスおよびその使用 |
US20070196820A1 (en) | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US7901950B2 (en) | 2005-08-12 | 2011-03-08 | Veridex, Llc | Method for assessing disease states by profile analysis of isolated circulating endothelial cells |
US9134237B2 (en) * | 2005-09-20 | 2015-09-15 | Janssen Diagnotics, LLC | High sensitivity multiparameter method for rare event analysis in a biological sample |
US9127302B2 (en) | 2005-09-20 | 2015-09-08 | Janssen Diagnostics, Llc | System for the detection and enumeration of suspect target cells in a mixed cell population |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
EP2029779A4 (de) | 2006-06-14 | 2010-01-20 | Living Microsystems Inc | Verwendung hoch paralleler snp-genotypisierung zur fötalen diagnose |
EP2589668A1 (de) | 2006-06-14 | 2013-05-08 | Verinata Health, Inc | Analyse seltener Zellen mittels Probentrennung und DNA-Etiketten |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
CN101583722A (zh) | 2006-07-14 | 2009-11-18 | 阿维瓦生物科学股份有限公司 | 从生物学样品检测稀有细胞的方法和组合物 |
CN202011883U (zh) | 2007-12-12 | 2011-10-19 | 里兰斯坦福初级大学理事会 | 用于捕获和分离目标细胞的装置 |
US8983580B2 (en) | 2008-01-18 | 2015-03-17 | The Board Of Trustees Of The University Of Illinois | Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors |
CA3069081C (en) | 2008-09-20 | 2023-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
EP2838581A4 (de) * | 2012-04-20 | 2016-03-02 | Agency Science Tech & Res | Vorrichtung und verfahren zum abtrennen einer biologischen einheit aus einem probenvolumen |
US9212976B2 (en) * | 2013-03-15 | 2015-12-15 | Qiagen Gaithersburg, Inc. | Vision-guided aspiration apparatus and methods |
CA2941801C (en) * | 2014-04-30 | 2018-09-11 | Ventana Medical Systems, Inc. | Hematoxylin precipitate cleaning method and system |
CN107850591A (zh) * | 2015-07-23 | 2018-03-27 | Hycor生物医学有限责任公司 | 在板上的套件 |
EP3693739A1 (de) * | 2019-02-06 | 2020-08-12 | Stefan Schreier | Verfahren und vorrichtung zur isolierung von gewünschten zellen aus einer probe nicht-magnetischer biologischer materialien |
CN111004706B (zh) * | 2019-12-23 | 2023-06-16 | 长春长光辰英生物科学仪器有限公司 | 一种用于微小尺寸目标分选仪器中的高通量接收系统 |
CN114196516B (zh) * | 2020-09-02 | 2023-09-26 | 浙江康是医疗器械有限公司 | 全自动便携式病毒采样管快速分析设备 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999041613A1 (en) * | 1998-02-12 | 1999-08-19 | Immunivest | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
JP2002323500A (ja) * | 1992-03-27 | 2002-11-08 | Abbott Lab | 自動連続ランダム・アクセス分析システムおよびその構成要素 |
WO2003065042A1 (en) * | 2001-02-16 | 2003-08-07 | Immunivest Corporation | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5784162A (en) * | 1993-08-18 | 1998-07-21 | Applied Spectral Imaging Ltd. | Spectral bio-imaging methods for biological research, medical diagnostics and therapy |
US5466574A (en) * | 1991-03-25 | 1995-11-14 | Immunivest Corporation | Apparatus and methods for magnetic separation featuring external magnetic means |
US6190617B1 (en) * | 1992-03-27 | 2001-02-20 | Abbott Laboratories | Sample container segment assembly |
US6500343B2 (en) * | 1995-02-21 | 2002-12-31 | Iqbal W. Siddiqi | Method for mixing and separation employing magnetic particles |
US20010018192A1 (en) * | 1998-02-12 | 2001-08-30 | Terstappen Leon W.M.M. | Labeled cells for use as an internal functional control in rare cell detection assays |
US6350613B1 (en) * | 1998-03-07 | 2002-02-26 | Belton Dickinson & Co. | Determination of white blood cell differential and reticulocyte counts |
ATE401574T1 (de) * | 2001-08-23 | 2008-08-15 | Immunivest Corp | Analyse zirkulierender tumorzellen, fragmente und trümmer |
-
2004
- 2004-09-17 EP EP04784320A patent/EP1673611A4/de not_active Withdrawn
- 2004-09-17 JP JP2006527036A patent/JP4629675B2/ja not_active Expired - Lifetime
- 2004-09-17 CA CA002539108A patent/CA2539108A1/en not_active Abandoned
- 2004-09-17 WO PCT/US2004/030429 patent/WO2005028663A2/en active Application Filing
-
2010
- 2010-10-19 JP JP2010234618A patent/JP5215368B2/ja not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002323500A (ja) * | 1992-03-27 | 2002-11-08 | Abbott Lab | 自動連続ランダム・アクセス分析システムおよびその構成要素 |
WO1999041613A1 (en) * | 1998-02-12 | 1999-08-19 | Immunivest | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
WO2003065042A1 (en) * | 2001-02-16 | 2003-08-07 | Immunivest Corporation | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
Also Published As
Publication number | Publication date |
---|---|
CA2539108A1 (en) | 2005-03-31 |
JP5215368B2 (ja) | 2013-06-19 |
WO2005028663A2 (en) | 2005-03-31 |
WO2005028663A3 (en) | 2005-12-22 |
JP2011097936A (ja) | 2011-05-19 |
JP2007505626A (ja) | 2007-03-15 |
EP1673611A2 (de) | 2006-06-28 |
EP1673611A4 (de) | 2011-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5215368B2 (ja) | オペレーター不要のプログラム可能な試料調製および分析システム | |
US8337755B2 (en) | Operator independent programmable sample preparation and analysis system | |
EP2124054B1 (de) | Immunodiagnostiktestvorrichtung mit mindestens einem Bildgerät, um Vorabagglutinationsschätzungen während eines Zentrifugationszyklus bereitzustellen | |
JP3682302B2 (ja) | 分注機による磁性体粒子の制御方法およびその装置 | |
KR102335824B1 (ko) | 원심분리기 및 반응조 유닛의 원심분리방법 | |
JP4950182B2 (ja) | 自動試験システム用の試薬およびサンプル処理装置 | |
US5631166A (en) | Specimen disk for blood analyses | |
EP1964613A2 (de) | Magnetscheider und Analysegerät damit | |
KR20160065943A (ko) | 응집반응 결과 판정방법 및 응집반응물 판정용 마이크로플레이트 | |
EP3757577B1 (de) | Automatisierte analysevorrichtung | |
JP2010054232A (ja) | 反応カード及び自動分析装置 | |
WO2002037078A2 (en) | Automated immunoassay analyzer and method of using the same | |
JP2002311034A (ja) | 免疫分析装置及び免疫分析方法 | |
US8784734B2 (en) | Reusable sheaths for separating magnetic particles | |
KR20230062601A (ko) | 마이크로웰 플레이트내 전혈 또는 다른 생물학적 샘플로부터 면역 세포의 직접 샘플링을 위한 자동화 방법 | |
JP2014228318A (ja) | 自動分析装置および自動分析方法 | |
US20230273206A1 (en) | Method of preparing a measurement specimen and specimen preparation apparatus | |
JP7161851B2 (ja) | 免疫測定装置の状態確認方法および免疫測定装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070731 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20090623 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100517 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100525 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100825 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100901 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100924 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101001 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101019 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20101109 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101111 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131119 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4629675 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |